A complete application in a minute
Tailored resume and cover letter, ready to send.
Scientia Clinical Research is seeking a motivated Clinical Study Coordinator to join our oncology-focused early‑phase trials team at the Prince of Wales Hospital campus in Randwick, NSW. This full‑time role involves coordinating studies from start‑up to close‑out, managing participant visits, data collection, and regulatory compliance under ICH‑GCP.
You will work with sponsors, investigators and study teams to support recruitment, ensure patient safety and data integrity, and contribute to
Scientia Clinical Research Ltd is a dedicated, not-for-profit, early-phase (Phase 1) clinical trials facility, that conducts studies for healthy volunteers and patients in areas like oncology. We are located at the Prince of Wales Hospital campus, Randwick NSW, and are equipped with an on-site laboratory, pharmacy, and a specialized cleanroom for compounding and manufacturing. We focus on first-in-human studies and collaborate with local research institutions to translate pre-clinical research into clinical trials.
Scientia Clinical Research (SCR) is seeking a motivated and detail-oriented Clinical Study Coordinator to join our growing team. This is a full‑time role. This is an exciting opportunity for a clinical research coordinator professional who is passionate about oncology research, patient care, quality, and regulatory compliance.
Working closely with Sponsors, CROs, Principal Investigators, oncologists, and multidisciplinary study teams, you will coordinate the day‑to‑day management of oncology clinical trials, ensuring studies are delivered efficiently, safely, and in accordance with protocol requirements, ICH‑GCP guidelines, company SOPs, and regulatory standards.
This role is ideally suited to an individual with experience in oncology clinical research who enjoys working directly with patients, investigators, and sponsors while contributing to the development of new cancer treatments.
As a Clinical Study Coordinator, you will play a central role in delivering high‑quality oncology clinical trials across Scientia's early-phase trails programs. You will coordinate studies from start‑up to close‑out, manage participant scheduling and study visits, perform protocol‑specific clinical procedures, and ensure all activities meet ICH‑GCP, NHMRC and regulatory standards. Acting as a key liaison for sponsors, CROs, investigators, clinicians, and participants, you will help drive recruitment, maintain study momentum, and uphold the highest standards of patient safety and data integrity.
In this role, you will maintain essential study documentation, support ethics and governance submissions, manage eCRFs and data queries, and contribute to quality, compliance, and continuous improvement initiatives. You will build strong relationships with internal and external stakeholders, support audits and monitoring visits, and assist with study tracking and budget‑related activities. This is a hands‑on, patient‑focused role suited to someone who thrives in a fast‑paced clinical research environment and is committed to delivering quality and excellence in oncology trial coordination.
We're seeking an experienced Clinical Study Coordinator (Oncology) with a tertiary qualification in Science, Medical Science, Nursing or a related discipline, and 2-3 years' experience in early-phase clinical study coordination. You will bring a solid understanding of ICH‑GCP, strong organisational and project coordination skills, and proven experience working within a clinical research site, hospital research unit, CRO or pharmaceutical environment. Experience performing clinical assessments (vital signs, ECGs, venepuncture), working with EDC systems, and supporting ethics and governance submissions will be highly regarded.
This role suits someone with exceptional attention to detail, strong organisation, planning and problem‑solving capability, and a commitment to quality, compliance, and patient‑centred care. You will be a collaborative team player who can work independently when needed, communicate confidently with stakeholders, and adapt to the fast‑paced demands of oncology trials.